Teva Pharma Industries Ltd ADR (TEVA) — the earnings record

Computed on 2026-09-18 from the vendor's per-print history with the Print Record's method — no desk-written read yet. An investment research diary, not advice.

The record at a glance

8/10EPS beats
8/10revenue beats
2 · 5 · 3up · flat · down (+3d, ±3%)
2026-11-04next print

Reactions across the covered prints span -6.8% to +7.2% — the beat column and the reaction column frequently disagree, which is the whole reason the record scores them separately. The street carries est EPS $0.71 · est revenue ~$4.23B into the next print.

Print by print

PrintDateEPSRevenue
Jul 26 2026-07-29 ✗ miss ✓ beat
Apr 26 2026-04-29 ✓ beat ✓ beat
Jan 26 2026-01-28 ✓ beat ✓ beat
Nov 25 2025-11-05 ✓ beat ✓ beat
Jul 25 2025-07-30 ✓ beat ✗ miss
May 25 2025-05-07 ✓ beat ✗ miss
Jan 25 2025-01-29 ✓ beat ✓ beat
Nov 24 2024-11-06 ✓ beat ✓ beat
Jul 24 2024-07-31 ✓ beat ✓ beat
May 24 2024-05-08 ✗ miss ✓ beat

Report-day close to the close three sessions later on adjusted closes, ±3% bands — the same method as every hand-written card; the Print Record method explains the bands. No reaction chart, metric line or behavior read exists for TEVA yet.

FAQ · from the current data · as of 2026-09-18

Quick answers

How often does Teva Pharma Industries Ltd ADR beat earnings estimates?

Across the last 10 covered prints (as of the 2026-09-18 card), Teva Pharma Industries Ltd ADR beat EPS estimates 8 of 10 times and revenue estimates 8 of 10 times, with 6 double beats.

How does TEVA stock react to earnings?

Measured close-of-print-day to the close three sessions later: 2 of the last 10 prints resolved up (beyond +3%), 5 flat, 3 down — reactions spanning -6.8% to +7.2%. Beat-or-miss and reaction are scored separately because they frequently disagree.

What was TEVA's biggest earnings reaction?

+7.2% over the three sessions after the May 24 print (2024-05-08).

When does Teva Pharma Industries Ltd ADR report earnings next?

2026-11-04 (2026-11-04 · est EPS $0.71 · est revenue ~$4.23B). This record is computed from the vendor's per-print history with the Print Record's method; a desk-written card for TEVA does not exist yet. An investment research diary, not advice.

Related in the Closelook universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.